Notes
Slide Show
Outline
1
Nutraceuticals for Gastrointestinal Disorders
  • Leo Galland, M.D., F.A.C.P.
  • Foundation for Integrated Medicine
  • www.mdheal.org
2
Nutraceuticals vs Pharmaceuticals
  • Pharmaceuticals are mostly used to suppress specific physiological functions:
  • PPIs, H2 blockers, calcium blockers, anticholinergic, antidopaminergic, anti-inflammatory, immunosuppressant.
  • Nutraceuticals may enhance physiologic function, complementing or replacing drugs. Some may act like drugs.


3
Esophageal Reflux
  • Results from reflex relaxation of the LES in response to gastric vagal mechanoreceptors (programmed in brainstem, unrelated to swallowing or gastric pH). Post-prandial gastric distension is a key trigger.
  • PPI’s and H-2 blockers convert acid reflux into non-acid reflux. Pepsin and bile present in gastric juice may yet act as esophageal irritants.
4
Toxicity of Acid Lowering Drugs
  • May increase development of atrophic gastritis in H. pylori-infected individuals
  • Allow gastric bacterial/yeast overgrowth and post-prandial intra-gastric production of ethanol and nitrosamines
  • May impair absorption of vitamin B12, folic acid, carotene, minerals and medication
  • Increase risk of hip fracture and pneumonia
5
Calcium vs GERD
  • With acute esophagitis, LES contraction becomes dependent upon extracellular Ca
  • Sohn et al, J Pharmacol Exp Ther. 1997;283:1293-304.


  • Intra-gastric calcium increases esophageal acid clearance and LES tone, independent of antacid effects, in patients with GERD.
  • Rodriguez-Stanley et al, Dig Dis Sci 2004; 49:1862-7


6
Non-Drug Treatment of GERD
  • Small meals eaten slowly in a relaxed fashion to decrease gastric distention. Chewing and swallowing enhance esophageal acid clearance.
  • Calcium citrate 250 mg after each meal
  • Postprandial enzymes
  • Red pepper powder 800 mg t.i.d.
  • Bortolotti et al, NEJM 2002; 346: 947-8.
  • Deglycyrrhizinated licorice, aloe, HCl (?)
7
TJ-43, aka Rikkunshi-to, Liu-Jun-Zi-Tang, Six Gentleman Formula
  • Speeds esophageal acid clearance in children with GERD, without increasing LES tone. Kawahara et al, Pediatr Surg Int. 2007
  •  Stimulates gastric emptying in dyspeptic adults. Tatsuta & Iishi, Aliment Pharmacol Ther. 1993
  • Increases gastric NO production in rats. Arakawa et al, Drugs Exp Clin Res. 1999
  • Raises plasma gastrin and somatostatin in human volunteers. Naito et al. Biol Pharm Bull. 2001



8
TJ-43 Components
  • Atractylodes lanceae rhizome
  • Ginseng root
  • Pinellia tuber
  • Hoelen
  • Zizyphus (jujube) fruit
  • Aurantii nobilis pericarp (orange peel)
  • Glycyrrhizae (licorice) root
  • Zingiberis (ginger) rhizome
  • Hesperidin and L-arginine are major ingredients
9
STW 5 (Iberogast) Relieves
Symptoms of Functional Dyspepsia
  • Iberis amara: prokinetic effects comparable to metoclopramide and cisapride without CNS/cardiotoxicity
  • Spasmolytic herbal extracts: German chamomile, angelica root, caraway, lemon balm, milk thistle, celandine, licorice, peppermint leaf.


  • Von Armin et al, Am J Gastroenterol. 2007
  • Meltzer et al, Aliment Pharmacol Ther. 2004
10
ASA/NSAID
Gastropathy/Enteropathy
  • Protective supplements (human trials):
    • Vit C  500-1000 mg bid
    • SAMe 500 mg/day
    • Cayenne 20 grams
    • Deglycyrrhizinated licorice 350 mg tid
    • Colostrum 125 mg tid
    •   L-glutamine 7 grams tid
11
Gastroprotection: Cayenne
  • Cayenne protects against aspirin-induced gastric mucosal damage in humans at a dose of 20 g administered 30 minutes before 600 mg of aspirin. Yeoh et al, Dig Dis Sci 1995.
  • Capsaicin is gastroprotective against a range of mucosal toxins in rats but may exert its effects by irritant-induced pre-conditioning, stimulating gastric mucus secretion.
  • Patients with recurrent/chronic abdominal pain, cayenne aggravates 25-50%. Kang et al, Gut 1992
12
Gastroprotection: Vitamin C
  • ASA inhibits absorption of vitamin C
  • ASA 400 mg bid for 3 days depletes intragastric vitamin C, suppresses gastric blood flow, SOD, GPx. Prevented by Vitamin C 480 mg b.i.d.
  • Healthy volunteers:
    • Adding C reduced ASA-induced gastric lesions
    • C 1000 mg b.i.d. for 3 days prevented ASA-induced duodenal injury


13
Gastroprotection: SAMe
  • S-adenosylmethionine (500 mg) given with aspirin (1300 mg) reduced by 95% the extent of aspirin-induced erosive gastritis in a single-dose study of healthy volunteers. Laudanno et al, Acta Gastroenterol Latinoam 1984.
  • Similar protective effects have been demonstrated in rats.
  • Yet, the most common side effect of SAMe is abdominal pain.
14
H. Pylori Inhibition in vitro
  • Mastic gum (P lentiscus), used for treatment of dyspepsia, kills H. pylori, but failed a clinical trial
  • Raw garlic and aqueous garlic extract inhibit growth (thiosulfinate, MIC of 40 mcg/ml)
  • Sulforaphane (cabbage and broccoli) has MIC of <4 mcg/ml (cabbage juice and broccoli sprouts have been used to treat PUD)
  • Lactobacilli inhibit growth


15
Adjunctive Therapy of H. pylori
Human Studies
  • Probiotics decrease treatment side effects with inconsistent effects on outcome
  • Bovine lactoferrin 200 mg bid, may increase therapeutic response and/or decrease side effects
  • N-acetyl cysteine liquid 400 mg tid, increased response to clarithromycin/lansozrapole.
  •  Gurbuz, South Med J. 2005;98:1095-7.
16
Irritable Bowel Syndromes:
a moving target
  • Motility
  • Stress and anxiety
  • Flora
  • Digestion and fermentation
  • Allergy and specific food intolerance
  • Pain sensitivity
  • Inflammation
17
IBS: Triggers
  • Stressful thoughts/events
  • Microbes
    • Bacteria
    • Yeast
    • Parasites
  • Food
    • Fiber/lack of fiber
    • Carbohydrate, form and amount
    • Specific food intolerance/allergy
18
 CAUSES OF UPPER GI BACTERIAL OVERGROWTH
  • Fistulas
  • Diverticulosis
  • Immune deficiency
  • Intestinal giardiasis
  • Tropical sprue
  • Malnutrition
  • Achlorhydria/hypo-chlorhydria
  • Surgical resection/blind loops
  • Stasis from abnormal motility
  • Strictures
19
EFFECTS OF UPPER GI BACTERIAL OVERGROWTH
  • Carbohydrate/fiber intolerance, bloating, altered bowel habit, fatigue
  • Vitamin B12 deficiency
  • Bile salt dehydroxylation
    • Impairs formation of micelles
  • Bile salt deconjugation
    • Increases colonic water secretion
    • Inhibit monosaccharide transport
20
BREATH TESTING FOR BACTERIAL OVERGROWTH
  • FALSE POSITIVES
    • Smoking, sleeping, eating
    • Soluble fiber/FOS
    • Rapid intestinal transit
  • FALSE NEGATIVES
    • Colonic hyperacidity (low stool pH)
    • Absence of appropriate flora
    • Delayed gastric emptying
    • Antibiotics


21
BACTERIAL OVERGROWTH IS MORE COMMON THAN SUSPECTED
  • 202 patients with IBS underwent hydrogen breath testing
  • 157 (78%) had SBBO and were treated with antibiotics
  • 25/47 patients had normal breath tests at follow-up
  • Diarrhea and abdominal pain were significantly improved by treatment
22
SBBO AND IBS: CONCLUSIONS
  • Elimination of SBBO eliminated IBS in 12/25 of patients:
  •    48 % of patients with IBS and abnormal breath tests who responded to antibiotics with normal breath tests no longer met Rome criteria for IBS
  • Pimentel M et al, AM J Gastroenterol 2000
23
MANAGEMENT OF UGI BACTERIAL OVERGROWTH INVOLVES DIET, ANTIBIOTICS
  • Low fermentation diet
  • -restrict sugar, starch, soluble fiber
  • Antimicrobials (in select cases):
    • Metronidazole (anaerobes)
    • Tetracyclines (anaerobes)
    • Ciprofloxacin (aerobes)
    • Bismuth
    • Bentonite



24
Low Fermentation Diet
  • Basic diet: no wheat, sucrose, lactose
  • Additional restrictions
  • -no glutinous grains
  • -no cereal grains, potatoes
  • -restrict fruits, juices, honey
  • -restrict fructose, fructans
  • -avoid legumes
  • -cook all vegetables
25
A Drug-Free
Clinical Approach to IBS
  • Avoid/reduce medications with GI side effects
  • Evaluate the role of infection or microbial overgrowth/deficit (dysbiosis)
  • Individualized dietary prescription
  • Stress management, hypnotherapy
  • Nutraceutical decision tree



26
Supplements for IBS
  • Probiotics
  • Prebiotics
  • Antimicrobial
  • Spasmolytic
  • Motility enhancing
  • Laxative
  • Antidiarrheal
27
Probiotics
  • Lactic acid producers: Lactobacilli (acidophilus, plantarum, casei, salivarius, reuterri, sporogenes), Bifidobacteria, Streptococci
  • Non-pathogenic E. coli
  • Soil-derived organisms: Bacilli (laterosporus, subtilis)
  • Saccharomyces boulardii (yeast against yeast)


28
Prebiotics
  • Foods that support the growth of probiotics: bran, psyllium, resistant starch (high amylose), oligofructose (FOS), inulin, germinated barley foodstuff (GBF), synthetic oligosaccharides
  • FOS is found in onions, garlic, rye, blueberries, bananas, chicory. Dietary intake averages 2-8 gm/day.
  • Inulins are derived from chicory and artichoke



29
Clinical Uses of Probiotics
  • Antibiotic-induced diarrhea
  • Traveler's diarrhea/acute GI infections
  • Irritable bowel syndromes
  • Inflammatory bowel disease
  • Diverticulitis
  • Colon cancer prevention
30
LACTOBACILLI: 
BENEFICIAL EFFECTS
  • Produce organic acids:  lower bowel pH
  • Produce H202
  • Antagonize enteropathogenic E. Coli, Salmonella, Staphylococci, Candida albicans, and Clostridia spp
  • Degrade N-nitrosamines
  • Anti-tumor glycopeptides (L. bulgaricus)
  • Stimulate balanced immune responses
  • Decrease rate of post-op infection (L plantarum)
31
BENEFITS OF SACCHAROMYCES BOULARDII
  • Stimulates production of sIgA
  • Protects against antibiotic and traveler’s diarrhea
  • Helps reverse C difficile colitis
  • Improves acute diarrheal disease in children
  • SAIF inhibits NFkB induction of IL-8 gene expression
32
Clinical uses of Prebiotics and Fiber
  • Irritable bowel syndromes
  • Ulcerative colitis
  • Prevention of colon cancer
  • Prevention of diverticulitis
33
Herbs Used for IBS Treatment
  • Aloe, various species
  • Fennel seed (Foeniculum vulgaris)
  • Ginger (Zingiber officinalis)
  • Slippery elm bark (Ulmus rubra)
  • Marshmallow root (Althea officinalis)
  • Cumin (Curcuma longa)
  • Chamomile, various species
  • Caraway (Carum copticum)
  • Lemon balm (Melissa officinalis)
  • Triphala (Terminalia chebula/belerica, Emblica officalis)
34
Peppermint Oil for IBS
  • Enteric coated peppermint oil is twice as effective as placebo for symptom relief; effect lasts after Rx ends. Capello et al, Dig Liver Dis. 2007
  • Inhibits gall bladder contraction, small bowel transit, colonic motility Goerg, Spilker Aliment Pharmacol Ther. 2003 ; Asao et al, Gastrointest Endosc. 2001
  • Reduces cellular calcium influx. Hills, Aaronson Gastroenterology. 1991
  • Decreases sulfide production by gut flora Ushid et al, J Nutr Sci Vitaminol (Tokyo). 2002
  • Kills trophozoites of Giardia lamblia. Vidal et al, Exp. Parasitol. 2007



35
TCM for Symptoms of IBS
  • Individualized vs standard formula vs placebo: short-term benefits from both formulas, post-treatment benefits only in the individualized treatment group. Bensoussan et al, JAMA 1998
  • Standarized formula no better than placebo. Leung et al, Am J Gastroenterol. 2006
36
Calcium and Fiber for
Chronic Diarrhea
  • Combination of psyllium and calcium was more effective and better tolerated than loperamide for controlling symptoms of chronic diarrhea. Qvitzau et al, Scand J Gastroenterol. 1988
  • Psyllium does not prevent calcium absorption in humans, contrary to animal data. Heaney & Weaver, J Am Geriatr Soc. 1995
37
Inflammatory Bowel Disease:
Dietary Decisions
  • Dietary responses may differ for Crohn’s disease and ulcerative colitis.
  • Avoid sucrose and symptom-provoking foods.
  • The specific carbohydrate diet (SCD), an exclusion diet or a defined formula diet may help relieve symptoms and may help induce or maintain remission (Crohn’s).
  • Replace vegetable oils with flaxseed oil and/or coconut oil (1 to tablespoons a day)
  • Oat bran 60 grams a day for patients with mild to moderate ulcerative colitis


38
Germinated Barley Foodstuff (GBF) and Ulcerative Colitis
  • GBF 20-30 gm/day helps to induce and maintain remission in patients with ulcerative colitis.
  • Mechanism: Increased colonic butyrate production decreases NFkB activation.


  •                  Hanai et al. Int J Mol Med. 2004 May;13(5):643-7.
  •       Kanauchi et al. J Gastroenterol. 2003;38:134-41.
  •       Kanauchi et al, Int J Mol Med. 2003;12:701-4
  •       Kanauchi et al. J Gastroenterol. 2002; 37 Suppl 14:67-72.
  • .


39
Vitamins and IBD
  • Folic acid, 800 mcg/day or more, especially for patients with high homocysteine or taking 5-ASA derivatrive
  •  Vitamin B12, 1000 mcg a month for patients with CD, those receiving folic acid or with high homocysteine
  • Vitamin B6, 10 to 20 mg/day, especially for patients with high homocysteine or taking high dose folic acid
  • Vitamin D3, 1000 IU/day or more to maintain levels of 25-OH vitamin D at 40 mcg/ml
  • An antioxidant supplying vitamin E 400 IU/day and vitamin C 500 to 1000 mg/day
  • Vitamin K, optimal dose unknown


40
Minerals and IBD
  • Zinc, 25 to 200 mg/day, to maintain plasma zinc above 800 mg/L
  • Calcium 1000 mg/day for patients on steroids or with low dietary calcium.
  • Selenium 200 mcg/day, especially for patients with ileal resection or on liquid formula diets
  • Magnesium citrate (150 to 900 mg/day) for patients with urolithiasis.
  • Chromium 600 mcg/day for patients with steroid-induced hyperglycemia.


41
Biologicals and IBD-1
  • Fish oils supplying 4000 to 5000 mg/day of omega-3 fatty acids (EPA + DHA)
  • VSL-3 (one sachet twice a day) for patients with mild to moderate UC  or pouchitis.
  • S. boulardii 250 mg t.i.d. or 500 mg b.i.d. for patients with chronic stable disease or to maintain remission


42
Biologicals and IBD-2
  • DHEA 200 mg/day for patients with refractory disease and low DHEA-S
  • N-acetyl glucosamine 3000 to 6000 mg/day
  • Boswellia serrata gum resin, 350 mg t.i.d.
  • Aloe vera gel 100 ml b.i.d for patients with ulcerative colitis
  • Mastic gum 1000 mg twice a day, tested in Crohn’s disease